Dr. Diana Deister reviews the epidemiology of substance use disorders, risk factors for development of substance use disorders in the pediatric pain population, diagnosis of substance use disorders, a brief screening tool to predict the risk of existing substance use disorders, and when to refer for additional treatment. The presentation was recorded at Effective Pediatric Pain Management and End of Life Care, on March 6, 2021.
Adolescent Substance Use and Addiction Program
Assistant in Medicine, Department of Pediatrics
At the conclusion of this educational program, learners will be able to:
- Identify risk factors for development of substance use disorders (SUD’s) in the pediatric pain population.
- Describe local epidemiology regarding opioid death.
- Apply criteria for diagnosis of SUD’s.
- Use a brief screening tool to predict risk of existing SUD’s, and when to refer for additional treatment.
In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston Children’s Hospital designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
This activity meets the requirements for 0.75 Risk Management Credits as proscribed by the Massachusetts Board of Registration in Medicine and defined in 243 CMR 2.06(5)(d) I. Please check your individual state licensing board requirements before claiming these credits.
Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.
The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients:
Diana Deister, MD, MS: None